Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 402

2.

The use of xenograft models for the selection of cancer treatments with the EGFR as an example.

Troiani T, Schettino C, Martinelli E, Morgillo F, Tortora G, Ciardiello F.

Crit Rev Oncol Hematol. 2008 Mar;65(3):200-11. Review.

PMID:
18389522
3.

On the development of models in mice of advanced visceral metastatic disease for anti-cancer drug testing.

Man S, Munoz R, Kerbel RS.

Cancer Metastasis Rev. 2007 Dec;26(3-4):737-47. Review.

PMID:
17846863
4.

Mouse models in oncogenesis and cancer therapy.

Céspedes MV, Casanova I, Parreño M, Mangues R.

Clin Transl Oncol. 2006 May;8(5):318-29. Review.

PMID:
16760006
5.
6.

An orthotopic metastatic prostate cancer model in SCID mice via grafting of a transplantable human prostate tumor line.

Wang Y, Xue H, Cutz JC, Bayani J, Mawji NR, Chen WG, Goetz LJ, Hayward SW, Sadar MD, Gilks CB, Gout PW, Squire JA, Cunha GR, Wang YZ.

Lab Invest. 2005 Nov;85(11):1392-404.

7.
8.

Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models.

Voskoglou-Nomikos T, Pater JL, Seymour L.

Clin Cancer Res. 2003 Sep 15;9(11):4227-39. Review.

9.
10.

Contributions of human tumor xenografts to anticancer drug development.

Sausville EA, Burger AM.

Cancer Res. 2006 Apr 1;66(7):3351-4, discussion 3354. Review.

11.

Dietary genistein reduces metastasis in a postsurgical orthotopic breast cancer model.

Vantyghem SA, Wilson SM, Postenka CO, Al-Katib W, Tuck AB, Chambers AF.

Cancer Res. 2005 Apr 15;65(8):3396-403.

12.

Growth and metastasis of surgical specimens of human breast carcinomas in SCID mice.

Sakakibara T, Xu Y, Bumpers HL, Chen FA, Bankert RB, Arredondo MA, Edge SB, Repasky EA.

Cancer J Sci Am. 1996 Sep-Oct;2(5):291-300.

PMID:
9166547
13.
14.
15.

In vivo evaluation of ixabepilone (BMS247550), a novel epothilone B derivative, against pediatric cancer models.

Peterson JK, Tucker C, Favours E, Cheshire PJ, Creech J, Billups CA, Smykla R, Lee FY, Houghton PJ.

Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6950-8.

16.

Human tumor xenografts in the nude mouse and their value as test models in anticancer drug development (review).

Winograd B, Boven E, Lobbezoo MW, Pinedo HM.

In Vivo. 1987 Jan-Feb;1(1):1-13. Review.

PMID:
2979758
18.

[Predictability of preclinical evaluation of anticancer drugs by human gastrointestinal cancer--nude mouse panel].

Fujita M, Fujita F, Sakamoto Y, Sugimoto T, Shimozuma K, Taguchi T.

Gan To Kagaku Ryoho. 1991 Jul;18(9):1429-37. Japanese.

PMID:
1854213
19.
20.

The pediatric preclinical testing program: description of models and early testing results.

Houghton PJ, Morton CL, Tucker C, Payne D, Favours E, Cole C, Gorlick R, Kolb EA, Zhang W, Lock R, Carol H, Tajbakhsh M, Reynolds CP, Maris JM, Courtright J, Keir ST, Friedman HS, Stopford C, Zeidner J, Wu J, Liu T, Billups CA, Khan J, Ansher S, Zhang J, Smith MA.

Pediatr Blood Cancer. 2007 Dec;49(7):928-40.

PMID:
17066459

Supplemental Content

Support Center